Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Gene Editing
Recent news which mentions Gene Editing
Biotech ETF SBIO Sees Buy Signal Amid Hot Returns
December 14, 2023
Tickers
ACAD
ALPS
SBIO
ZLAB
Tags
ACAD
SBIO
biotech investing
From
ETF Trends
Play US Gene Treatment Approval in SBIO
December 07, 2023
Tickers
ALPS
SBIO
Tags
ETF Building Blocks Channel
biotech etf
ALPS
From
ETF Trends
Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade
February 06, 2023
Tickers
TECH
Tags
Tech
Jennifer Doudna
Gene Editing
From
Benzinga
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection
September 19, 2022
Tickers
BEAM
Tags
General
BEAM
Market News
From
Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
General
Small Cap
FDA
From
Benzinga
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
Tags
Market News
Trading Ideas
Health Care
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
Benzinga
Movers
Biotech
From
Benzinga
Sarepta Bets On GenEdit's Nanoparticles' In $57M Gene Editing Partnership
February 01, 2022
Tickers
SRPT
Tags
Benzinga
Health Care
Biotech
From
Benzinga
Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs
January 10, 2022
Tickers
BEAM
PFE
Tags
BEAM
Contracts
why it's moving
From
Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
October 26, 2021
Tickers
VRTX
Tags
Benzinga
VRTX
Biotech
From
Benzinga
Sana Obtains License To Beam Therapeutics' CRISPR Cas12b Gene Editing Technology
October 19, 2021
Tickers
BEAM
SANA
Tags
Briefs
Biotech
Movers
From
Benzinga
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
Tickers
NTLA
Tags
News
Gene Editing
Phase 1 Trial
From
Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
September 29, 2021
Tickers
EDIT
Tags
Phase 2 Trial
General
Benzinga
From
Benzinga
Wave Life Sciences Shows Durable ADAR-Editing In Multiple Tissues In Animal Studies
September 29, 2021
Tickers
WVE
Tags
Briefs
News
Gene Editing
From
Benzinga
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection
September 27, 2021
Tickers
BEAM
Tags
Preclinical Phase
Market News
General
From
Benzinga
Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal Studies
September 23, 2021
Tickers
BEAM
Tags
Market News
Preclinical Phase
General
From
Benzinga
How Colossal sold investors on a quest to resurrect a woolly mammoth
September 13, 2021
Tickers
TC
Tags
mammoth
Science
CRISPR
From
TechCrunch
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
September 09, 2021
Tickers
TC
Tags
jennifer doudna
therapeutics
CRISPR
From
TechCrunch
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
August 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
RHHBF
From
Benzinga
Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies
August 24, 2021
Tickers
VRTX
Tags
Gene Editing
News
Health Care
From
Benzinga
Editas Medicine Unveils Preclinical Data From New Gene Editing Technology
August 23, 2021
Tickers
EDIT
Tags
Health Care
Trading Ideas
EDIT
From
Benzinga
New Technologies Driving the Future of Plant Breeding
August 10, 2021
Tags
Innovation & Technology
FWB:BAYN
Plant Breeding
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
July 20, 2021
Tickers
GENE
GRPH
Tags
gene
GRPH
Dr/ Matthew Porteus
From
Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
July 12, 2021
Tickers
FPX
IPO
IPOS
Tags
Briefs
IPO
Benzinga
From
Benzinga
WHO Issues Framework For Governance For Gene Editing Technologies
July 12, 2021
Tickers
BEAM
CRSP
EDIT
NTLA
Tags
Regulations
Health Care
NTLA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.